Biological Function of Long Non-coding RNA (LncRNA) Xist
- PMID: 34178980
- PMCID: PMC8222981
- DOI: 10.3389/fcell.2021.645647
Biological Function of Long Non-coding RNA (LncRNA) Xist
Abstract
Long non-coding RNAs (lncRNAs) regulate gene expression in a variety of ways at epigenetic, chromatin remodeling, transcriptional, and translational levels. Accumulating evidence suggests that lncRNA X-inactive specific transcript (lncRNA Xist) serves as an important regulator of cell growth and development. Despites its original roles in X-chromosome dosage compensation, lncRNA Xist also participates in the development of tumor and other human diseases by functioning as a competing endogenous RNA (ceRNA). In this review, we comprehensively summarized recent progress in understanding the cellular functions of lncRNA Xist in mammalian cells and discussed current knowledge regarding the ceRNA network of lncRNA Xist in various diseases. Long non-coding RNAs (lncRNAs) are transcripts that are more than 200 nt in length and without an apparent protein-coding capacity (Furlan and Rougeulle, 2016; Maduro et al., 2016). These RNAs are believed to be transcribed by the approximately 98-99% non-coding regions of the human genome (Derrien et al., 2012; Fu, 2014; Montalbano et al., 2017; Slack and Chinnaiyan, 2019), as well as a large variety of genomic regions, such as exonic, tronic, and intergenic regions. Hence, lncRNAs are also divided into eight categories: Intergenic lncRNAs, Intronic lncRNAs, Enhancer lncRNAs, Promoter lncRNAs, Natural antisense/sense lncRNAs, Small nucleolar RNA-ended lncRNAs (sno-lncRNAs), Bidirectional lncRNAs, and non-poly(A) lncRNAs (Ma et al., 2013; Devaux et al., 2015; St Laurent et al., 2015; Chen, 2016; Quinn and Chang, 2016; Richard and Eichhorn, 2018; Connerty et al., 2020). A range of evidence has suggested that lncRNAs function as key regulators in crucial cellular functions, including proliferation, differentiation, apoptosis, migration, and invasion, by regulating the expression level of target genes via epigenomic, transcriptional, or post-transcriptional approaches (Cao et al., 2018). Moreover, lncRNAs detected in body fluids were also believed to serve as potential biomarkers for the diagnosis, prognosis, and monitoring of disease progression, and act as novel and potential drug targets for therapeutic exploitation in human disease (Jiang W. et al., 2018; Zhou et al., 2019a). Long non-coding RNA X-inactive specific transcript (lncRNA Xist) are a set of 15,000-20,000 nt sequences localized in the X chromosome inactivation center (XIC) of chromosome Xq13.2 (Brown et al., 1992; Debrand et al., 1998; Kay, 1998; Lee et al., 2013; da Rocha and Heard, 2017; Yang Z. et al., 2018; Brockdorff, 2019). Previous studies have indicated that lncRNA Xist regulate X chromosome inactivation (XCI), resulting in the inheritable silencing of one of the X-chromosomes during female cell development. Also, it serves a vital regulatory function in the whole spectrum of human disease (notably cancer) and can be used as a novel diagnostic and prognostic biomarker and as a potential therapeutic target for human disease in the clinic (Liu et al., 2018b; Deng et al., 2019; Dinescu et al., 2019; Mutzel and Schulz, 2020; Patrat et al., 2020; Wang et al., 2020a). In particular, lncRNA Xist have been demonstrated to be involved in the development of multiple types of tumors including brain tumor, Leukemia, lung cancer, breast cancer, and liver cancer, with the prominent examples outlined in Table 1. It was also believed that lncRNA Xist (Chaligne and Heard, 2014; Yang Z. et al., 2018) contributed to other diseases, such as pulmonary fibrosis, inflammation, neuropathic pain, cardiomyocyte hypertrophy, and osteoarthritis chondrocytes, and more specific details can be found in Table 2. This review summarizes the current knowledge on the regulatory mechanisms of lncRNA Xist on both chromosome dosage compensation and pathogenesis (especially cancer) processes, with a focus on the regulatory network of lncRNA Xist in human disease.
Keywords: X-chromosome inactivation; X-chromosome inactivation center; cancer; disease; lncRNA Xist; long non-coding RNA.
Copyright © 2021 Wang, Min, Qiu, Wu, Liu, Ma, Zhang and Zhu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



Similar articles
-
3D genomic regulation of lncRNA and Xist in X chromosome.Semin Cell Dev Biol. 2019 Jun;90:174-180. doi: 10.1016/j.semcdb.2018.07.013. Epub 2018 Jul 14. Semin Cell Dev Biol. 2019. PMID: 30017906 Review.
-
X-inactive-specific transcript: a long noncoding RNA with a complex role in sex differences in human disease.Biol Sex Differ. 2024 Dec 5;15(1):101. doi: 10.1186/s13293-024-00681-5. Biol Sex Differ. 2024. PMID: 39639337 Free PMC article. Review.
-
Long non-coding RNAs: From disease code to drug role.Acta Pharm Sin B. 2021 Feb;11(2):340-354. doi: 10.1016/j.apsb.2020.10.001. Epub 2020 Oct 10. Acta Pharm Sin B. 2021. PMID: 33643816 Free PMC article. Review.
-
Long noncoding RNA in genome regulation: prospects and mechanisms.RNA Biol. 2010 Sep-Oct;7(5):582-5. doi: 10.4161/rna.7.5.13216. Epub 2010 Sep 1. RNA Biol. 2010. PMID: 20930520 Free PMC article.
-
Spen links RNA-mediated endogenous retrovirus silencing and X chromosome inactivation.Elife. 2020 May 7;9:e54508. doi: 10.7554/eLife.54508. Elife. 2020. PMID: 32379046 Free PMC article.
Cited by
-
lncRNA XIST Interacts with Regulatory T Cells within the Tumor Microenvironment in Chronic Hepatitis B-Associated Hepatocellular Carcinoma.Turk Patoloji Derg. 2024;40(2):101-108. doi: 10.5146/tjpath.2023.13161. Turk Patoloji Derg. 2024. PMID: 38265097 Free PMC article.
-
LncRNA SNHG7 promotes non-small cell lung cancer progression and cisplatin resistance by inducing autophagic activity.J Thorac Dis. 2023 Jan 31;15(1):155-167. doi: 10.21037/jtd-22-1826. Epub 2023 Jan 16. J Thorac Dis. 2023. PMID: 36794139 Free PMC article.
-
Microarray analysis of long non-coding RNAs related to osteogenic differentiation of human dental pulp stem cells.J Dent Sci. 2022 Apr;17(2):733-743. doi: 10.1016/j.jds.2021.10.014. Epub 2021 Nov 4. J Dent Sci. 2022. PMID: 35756759 Free PMC article.
-
Anti-oxidative-initiated cognitive impairment amelioration in Alzheimer's disease model rats through preventive transcutaneous electrical acupoint stimulation.Integr Med Res. 2023 Jun;12(2):100946. doi: 10.1016/j.imr.2023.100946. Epub 2023 Apr 3. Integr Med Res. 2023. PMID: 37187681 Free PMC article.
-
Significance of serum lncRNA XIST in chronic obstructive pulmonary disease and its progression to pulmonary heart disease.BMC Pulm Med. 2024 Oct 31;24(1):546. doi: 10.1186/s12890-024-03354-6. BMC Pulm Med. 2024. PMID: 39482714 Free PMC article.
References
-
- Agrelo R., Wutz A. (2010). X inactivation and disease. Semin. Cell Dev. Biol. 21 194–200. - PubMed
-
- An C., Feng G., Zhang J., Cao S., Wang Y., Wang N., et al. (2020). Overcoming autocrine FGF signaling-induced heterogeneity in naive human ESCs enables modeling of random X chromosome inactivation. Cell Stem Cell 27 482.e4–497.e4. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials